Senna Plus: Package Insert and Label Information

SENNA PLUS- sennosides and docusate sodium tablet, film coated
CARDINAL HEALTH, 110 DBA LEADER

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active Ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

Stool Softener

Laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours

Warnings

Do not use

  • if you are taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after the use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

  • take preferably at bedtime or as directed by a doctor

age

starting dosage

maximum dosage

adults and children 12 years and over

2 tablets once a day

4 tablets twice a day

children 6 to under 12 years

1 tablet once a day

2 tablets twice a day

children 2 to under 6 years

1/2 tablet once a day

1 tablet twice a day

children under 2 years

ask a doctor

ask a doctor

Other information

  • each tablet contains: calcium 10 mg, sodium 5 mg, Very Low Sodium
  • store at 20-25°C(68-77°F); excursions permitted between 15o -30o C (59o -86o F)

Inactive ingredients

croscarmellose sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium benzoate, talc, titanium dioxide

Questions or comments?

(866) 562-2756 (Mon-Fri 8 AM to 4 PM EST)

LEADER TM

NDC 70000-0520-1

Senna Plus

Docusate Sodium, 50 mg

Sennosides, 8.6 mg

Stool Softener l Laxative

Dual Action

Standardized

Senna Concentrate

COMPARE TO

SENOKOT-S®

active ingredients*

100% Money

Back Guarantee

30 TABLETS

Leader Senna Plus Tablet 30 ct. Product Label
(click image for full-size original)

SENNA PLUS
docusate sodium 50 mg and sennosides 8.6 mg tablet, film coated
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:70000-0520
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SENNOSIDES (SENNOSIDES) SENNOSIDES 8.6 mg
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 50 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
D&C YELLOW NO. 10
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
FD&C YELLOW NO. 6
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYVINYL ALCOHOL, UNSPECIFIED
SODIUM BENZOATE
TALC
TITANIUM DIOXIDE
Product Characteristics
Color orange (ORANGE COLOR) Score no score
Shape ROUND (ROUND TABLET) Size 10mm
Flavor Imprint Code PH32
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70000-0520-1 30 BOTTLE, PLASTIC in 1 CARTON contains a BOTTLE, PLASTIC
1 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC This package is contained within the CARTON (70000-0520-1)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part334 10/23/2019
Labeler — CARDINAL HEALTH, 110 DBA LEADER (063997360)
Registrant — Pharbest Pharmaceuticals, Inc. (557054835)
Establishment
Name Address ID/FEI Operations
Pharbest Pharmaceuticals, Inc. 557054835 manufacture (70000-0520), analysis (70000-0520), pack (70000-0520), label (70000-0520)

Revised: 06/2021 CARDINAL HEALTH, 110 DBA LEADER

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.